FLT3 and cancer: In this respect, it is interesting that inhibitors of FLT3 have been approved for various cancers and have been trialed with positive effect for multiple T-cell-mediated auto-immune diseases [225] that are genetically and/or clinically overlapping/comorbid with TD [227,228,229].